Feb 11 2010
Strategic Diagnostics Inc. (Nasdaq: SDIX), a leading provider of
biotechnology-based products and services for a broad range of life
science, biotechnology, diagnostic, and food safety applications, today
announced it will be doing business as SDIX (Strategic Diagnostics Inc.
d/b/a SDIX).
The new SDIX name and logo are designed to better reflect the Company’s
evolution from its historical beginnings as an industrial diagnostics
products and antibody production company to a the company it is today, a
biotechnology company, with all of its core capabilities and expanded
expertise in developing and delivering a full suite of innovative
immuno-solutions. The new name also aligns the company name with its
website address and NASDAQ listing, making the company easier to find
and connect too.
Commenting on the announcement, Mr. Fran DiNuzzo, President and CEO of
SDIX said, “Over the last twenty years, Strategic Diagnostics Inc. has
grown by delivering value and innovation to our customers. Over the past
several years, the company has emerged as an innovative supplier of
immune-solutions to new customers in the Life Science market. As such,
the company has evolved beyond its name and brand.
Today, our company is much more than the original Strategic Diagnostics
name or SDI logo represented. We are transforming SDI into a
biotechnology company with a key focus on growth in the Life Science and
Food Safety markets. We intend for SDIX and our updated logo to
symbolize our commitment to be experts at creating advantage for our
customers and partners using quality, innovative, and effective
immuno-solutions.”
Source SDIX